LLY leans on tirzepatide and a deep late-stage pipeline to defend its obesity momentum as new rivals make rapid progress in ...
Eli Lilly’s latest weight-loss shot helped patients lose as much as 29 per cent of their body weight in trials, giving ...
In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
Moderna is seeking to enhance some of its drugs with Nanexa’s technology as the biologics sector moves to less frequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback